TABLE 4

Comparison of SUVmax in Malignant Lesions With and Without ADT

ParameterOngoing ADTNo ADTP
Local recurrence6.6 ± 2.85.9 ± 2.00.41
LN metastases5.1 ± 2.57.1 ± 3.40.24
Bone metastases13.4 ± 7.85.9 ± 2.30.15